Compare KYMR & PRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KYMR | PRM |
|---|---|---|
| Founded | 2015 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Newspapers/Magazines |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.2B |
| IPO Year | 2020 | N/A |
| Metric | KYMR | PRM |
|---|---|---|
| Price | $81.32 | $28.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 23 | 2 |
| Target Price | ★ $105.35 | $25.00 |
| AVG Volume (30 Days) | ★ 1.4M | 915.0K |
| Earning Date | 11-04-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.52 |
| Revenue | $43,735,000.00 | ★ $636,343,000.00 |
| Revenue This Year | $18.71 | $15.76 |
| Revenue Next Year | N/A | $14.03 |
| P/E Ratio | ★ N/A | $53.72 |
| Revenue Growth | N/A | ★ 19.12 |
| 52 Week Low | $19.45 | $8.76 |
| 52 Week High | $103.00 | $29.78 |
| Indicator | KYMR | PRM |
|---|---|---|
| Relative Strength Index (RSI) | 56.53 | 59.07 |
| Support Level | $82.55 | $27.51 |
| Resistance Level | $85.41 | $28.60 |
| Average True Range (ATR) | 5.10 | 0.89 |
| MACD | -0.75 | -0.20 |
| Stochastic Oscillator | 14.43 | 41.97 |
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
Perimeter Solutions Inc is a solutions provider for the Fire Safety and Specialty Products industries. The Company's products and operations are managed and reported in two operating segments. Its Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services typically offered in conjunction with the Company's retardant and foam products. The Specialty Products segment includes operations that develop, produce and market products for non-fire safety markets. Specialty Products segment is Phosphorus Pentasulfide (P2S5) based lubricant additives. P2S5 is also used in pesticide and mining chemicals applications, and emerging electric battery technologies.